Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06170281 · ClinicalTrials.gov registry record · NA
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT06170281: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT06170281 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06170281, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study will unpack the behavioral intervention for migraine and determine the optimum combinations. In addition, the study will test preference and self-selection effects during the trial.
Interventions
- BEHAVIORAL Migraine Behavioral Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-12 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06170281
The ClinicalTrials.gov registry entry for NCT06170281 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Migraine Behavioral Treatment is the first listed.
NCT06170281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06170281 about?
NCT06170281 is a clinical study titled "Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial". This study will unpack the behavioral intervention for migraine and determine the optimum combinations. In addition, the study will test preference and self-selection effects during the trial.
What is the current status of trial NCT06170281?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-12. Estimated completion is 2028-12-01.
What interventions are being tested in trial NCT06170281?
The interventions under investigation include: Migraine Behavioral Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06170281?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.